Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Epigenetic and transcriptional alterations with Kmt2c and Kmt2d knockout

ABSTRACT: Epigenetic and transcriptional alterations with Kmt2c and Kmt2d knockout

PROVIDER: PRJNA1102881 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28759500_1.fastq.gz	Fastqsanger.gz
	SRR28759500_2.fastq.gz	Fastqsanger.gz
	SRR28759501_1.fastq.gz	Fastqsanger.gz
	SRR28759501_2.fastq.gz	Fastqsanger.gz
	SRR28759502_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 100

Similar Datasets

Epigenetic and transcriptional alterations with Kmt2c and Kmt2d knockout

Project description:KMT2C and KMT2D are two of the most frequently mutated genes in bladder cancer and in histologically normal urothelium. In this study, we developed mouse models to investigate the molecular mechanism of Kmt2c/d loss in urothelial tumorigenesis.

2024-08-09 | GSE264514 | GEO

Epigenetic and transcriptional alterations with Kmt2c and Kmt2d loss in urothelial cells

2024-08-09 | GSE236370 | GEO

Epigenetic and transcriptional alterations in Kmt2c/Kmt2d-deficient gastric cancer [ChIP-Seq]

Project description:KMT2C and KMT2D are two of the most frequently mutated genes in gastric adenocarcinoma, yet their function in cancer initiation remains poorly understood. In this study, we developed mouse models to investigate the molecular mechanism of Kmt2c/d loss in gastric tumorigenesis.

2026-04-28 | GSE317003 | GEO

Epigenetic and transcriptional alterations in Kmt2c/Kmt2d-deficient gastric cancer [RNA-seq]

2026-04-28 | GSE316994 | GEO

Epigenetic and transcriptional alterations in Kmt2c/Kmt2d-deficient gastric cancer [RNA-seq]

Project description:Epigenetic and transcriptional alterations in Kmt2c/Kmt2d-deficient gastric cancer [RNA-seq]

| PRJNA1405649 | ENA

Epigenetic and transcriptional alterations in Kmt2c/Kmt2d-deficient gastric cancer [ChIP-Seq]

Project description:Epigenetic and transcriptional alterations in Kmt2c/Kmt2d-deficient gastric cancer [ChIP-Seq]

| PRJNA1405663 | ENA

Epigenetic and transcriptional alterations with Kmt2c and Kmt2d loss in urothelial cells

Project description:Epigenetic and transcriptional alterations with Kmt2c and Kmt2d loss in urothelial cells

| PRJNA990720 | ENA

Single cell RNA sequencing analysis following Kmt2c/Kmt2d and Pten knockout in mouse stomach mucosa.

Project description:KMT2C, KMT2D and genes in PI3K pathway are frequently mutated in gastric cancer. In this study, we developed genetically engineered mouse models to knock out these genes in stomach mucosa and observed development of pre-cancerous and cancerous lesions. To investigate cellular differentiation and transcriptional alterations, we performed single cell RNA sequencing three weeks post gene knockout.

2026-04-27 | GSE292432 | GEO

Mass spectrometry of histone post-translational modifications in WT and KMT2C/2D dKO urothelial cells

Project description:KMT2C and KMT2D are two of the frequently mutated epigenetic modifiers in urothelial cancer. To compare the histone post-translational modification with Kmt2c/d loss, we performed mass spectrometry analysis of histones from Kmt2c/d WT and dKO urothelial cells.

2025-01-08 | PXD056439 | Pride

Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3

Project description:Histone lysine methyltransferases KMT2C and KMT2D are among the most commonly mutated genes in the highly metastatic TNBC subtype of breast cancer. However, it is not known if mutations of either of these genes similarly effect epigenomic and transcriptomic landscape or if a specific downstream target might influence metastases. Here, we generated heterogenous Kmt2c or Kmt2d KO murine TNBC cell lines side-by-side and performed in vivo metastases assay in syngeneic immunocompetent mice. Deficiency for either Kmt2c or Kmt2d, both, induced brain metastases from formerly non-metastatic cells. scRNAseq showed activation of pro-inflammatory pathways but conversely also increase of immune checkpoint blocking genes. Interestingly, histone mass spectrometry revealed changes of H3K27 but not the main substrate H3K4. However, ChIPseq for both, H3K4 and H3K27 modifications showed significant changes compared to wildtype cells. Strikingly, genome occupancy of H3K27me3 was reduced while H3K27 demethylase KDM6A was enriched on genomes of KO cells. Integration with gene expression data revealed significant correlations with histone and KDM6A ChIPseq, identifying them as a main driver of Kmt2c or Kmt2d KO-specific gene regulation. Although our datasets revealed more unique than shared signatures, we found Mmp3 being a common target upon Kmt2c or Kmt2d KO. Indeed, downregulation of Mmp3 reversed induction of Kmt2c and Kmt2d KO-dependent brain metastases. Finally, we found that Kdm6a knockdown reduces Mmp3 levels, again, leading to reduction of brain metastases of Kmt2c or Kmt2d KO cells.

2024-05-07 | MSV000094701 | MassIVE

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data